# A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body

> **NCT06572111** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1839100 (C-14) formulation 1
- **DRUG:** BI 1839100
- **DRUG:** BI 1839100 (C-14) formulation 2

## Key facts

- **NCT ID:** NCT06572111
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-09-30
- **Primary completion:** 2024-10-28
- **Final completion:** 2025-09-02
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Company decision
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06572111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06572111, "A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06572111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*